Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
20.07
-0.47 (-2.29%)
At close: Sep 4, 2026, 4:00 PM EDT
20.02
-0.05 (-0.25%)
After-hours: Sep 4, 2026, 4:16 PM EDT

Sutro Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
54.3458.13190.369.2747.2530.41
Short-Term Investments
110.0183.3126.59306.35287.11167.52
Cash & Short-Term Investments
164.35141.43316.9375.62334.36197.94
Cash Growth
-19.88%-55.37%-15.63%12.34%68.92%-46.23%
Receivables
5.83.988.6236.087.1212.45
Prepaid Expenses
5.55.5217.89.8511.678.12
Total Current Assets
175.65150.93343.31421.54353.15218.52
Property, Plant & Equipment
16.8221.5535.8744.7651.0651.59
Long-Term Investments
-----68.78
Other Long-Term Assets
1.991.358.034.442.732.53
Total Assets
194.46173.83387.21470.74406.94341.41

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.367.5710.489.444.86.01
Accrued Expenses
22.1933.7140.1334.124.8317.07
Current Portion of Long-Term Debt
---4.0612.59.38
Current Portion of Leases
6.667.787.486.424.591.04
Current Income Taxes Payable
--0.0215.17--
Current Unearned Revenue
6.4610.5669.7820.6716.765.5
Other Current Liabilities
14.2315.514.013.93.082.75
Total Current Liabilities
52.975.13131.8993.7566.5541.74
Long-Term Debt
----3.7715.74
Long-Term Leases
4.127.8915.6723.1529.5731.22
Long-Term Unearned Revenue
239.06221.56193.35202.4989.89-
Other Long-Term Liabilities
1.691.691.691.690.120.15
Total Liabilities
297.78306.28342.61321.09189.988.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.010.010.060.060.05
Additional Paid-In Capital
951.7845.48831.42708.98670.22586.24
Retained Earnings
-1,055-977.96-786.87-559.41-452.62-333.41
Comprehensive Income & Other
-0.060.020.040.02-0.62-0.31
Total Common Equity
-103.32-132.4544.6149.65217.05252.56
Shareholders' Equity
-103.32-132.4544.6149.65217.05252.56
Total Liabilities & Equity
194.46173.83387.21470.74406.94341.41

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
10.7815.6723.1533.6450.4357.37
Net Cash (Debt)
153.56125.75293.74341.98283.93209.34
Net Cash Growth
-17.23%-57.19%-14.11%20.45%35.63%-39.07%
Net Cash Per Share
13.1514.8037.9756.8455.9645.39
Filing Date Shares Outstanding
16.5816.578.386.246.024.64
Total Common Shares Outstanding
16.588.588.256.15.754.63
Working Capital
122.7575.79211.42327.8286.61176.78
Book Value Per Share
-6.23-15.435.4024.5337.7554.52
Tangible Book Value
-103.32-132.4544.6149.65217.05252.56
Tangible Book Value Per Share
-6.23-15.435.4024.5337.7554.52
Machinery
-25.5142.124037.6331.82
Construction In Progress
-0.150.50.51.690.51
Leasehold Improvements
-12.3424.2123.6123.2223.65
SEC Filings: 10-K · 10-Q